Literature DB >> 8012507

Influence of nitroglycerin on portal pressure and gastric mucosal hemodynamics in patients with cirrhosis.

H Noguchi1, A Toyonaga, K Tanikawa.   

Abstract

We studied 30 patients with cirrhosis to determine the effect of nitroglycerin on portal and gastric mucosal hemodynamics. Systemic hemodynamics, portal venous pressure (PVP), the hemoglobin index (IHB), and the oxygen saturation index (ISO2) of the gastric mucosa were measured before and after a continuous infusion of nitroglycerin. The patients were divided into two groups according to the presence or absence of major portal-systemic collateral routes on portograms. Nitroglycerin caused a reduction in PVP in all patients. Although there was no significant difference in systemic hemodynamic changes between the two groups, the reduction in PVP in patients with major portal-systemic collaterals was significantly higher than in those without major collaterals. A nitroglycerin infusion, at a dose of 1.0 micrograms/kg per min for 10 min, produced a reduction in both IHB (-16%, P < 0.001) and ISO2 (-13%, P < 0.001) in the gastric mucosa, indicating gastric mucosal ischemia secondary to splanchnic vasoconstriction. These findings suggest that the continuous infusion of nitroglycerin reduces PVP in cirrhotic patients, particularly in those with major portal-systemic collaterals, and reduces the congestion of the gastric mucosa in patients with portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012507     DOI: 10.1007/bf02358680

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  26 in total

1.  Portal hypertensive gastropathy in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Sumino; K Takagi; K Oho; M Nishizono; K Ohkubo; R Inoue; E Sasaki; K Tanikawa
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

2.  Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts. A preliminary report.

Authors:  K Okuda; K Suzuki; H Musha; N Arimuzu
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Nitroglycerin for portal hypertension. A controlled comparison of the hemodynamic effects of graded doses.

Authors:  W G Rector; K F Hossack; J B Ready
Journal:  J Hepatol       Date:  1990-05       Impact factor: 25.083

4.  Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: evidence for an impaired cardiopulmonary baroreflex function.

Authors:  R Moreau; D Roulot; A Braillon; C Gaudin; A Hadengue; Y Bacq; D Lebrec
Journal:  Hepatology       Date:  1989-07       Impact factor: 17.425

5.  Endoscopic demonstration that vasopressin but not propranolol produces gastric mucosal ischemia in dogs with portal hypertension.

Authors:  F W Leung; D M Jensen; P H Guth
Journal:  Gastrointest Endosc       Date:  1988 Jul-Aug       Impact factor: 9.427

6.  Reflectance spectrophotometry for the assessment of gastroduodenal mucosal perfusion.

Authors:  F W Leung; T Morishita; E H Livingston; T Reedy; P H Guth
Journal:  Am J Physiol       Date:  1987-06

7.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

Authors:  R J Groszmann; D Kravetz; J Bosch; M Glickman; J Bruix; J Bredfeldt; H O Conn; J Rodes; E H Storer
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

8.  Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Sumino; K Takagi; K Ohkubo; R Inoue; K Tanikawa
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

9.  The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.

Authors:  R J Kroeger; R J Groszmann
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

Review 10.  Drug therapy for portal hypertension.

Authors:  W G Rector
Journal:  Ann Intern Med       Date:  1986-07       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.